Applied DNA Sciences, Inc.
APDN · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,088 | -$9,947 | -$8,270 | -$14,278 |
| Dep. & Amort. | $696 | $1,362 | $1,290 | $844 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $572 | $1,034 | $2,519 | $1,668 |
| Change in WC | -$1,140 | $2,447 | $955 | -$3,616 |
| Other Non-Cash | -$6,752 | -$1,113 | -$5,470 | $1,994 |
| Operating Cash Flow | -$13,711 | -$6,218 | -$8,977 | -$13,388 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$408 | -$1,141 | -$490 | -$2,549 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $45 | $0 | $0 |
| Investing Cash Flow | -$408 | -$1,096 | -$490 | -$2,549 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$1,666 |
| Stock Issued | $13,398 | $0 | $14,427 | $13,757 |
| Stock Repurch. | $0 | $953 | $0 | $0 |
| Dividends Paid | -$233 | $0 | -$110 | $0 |
| Other Fin. Act. | $233 | $0 | $3,810 | $2,614 |
| Financing Cash Flow | $13,399 | $0 | $18,127 | $14,705 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$721 | -$7,313 | $8,660 | -$1,232 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,902 | $15,215 | $6,555 | $7,787 |
| End Cash | $7,181 | $7,902 | $15,215 | $6,555 |
| Free Cash Flow | -$14,119 | -$6,296 | -$9,466 | -$15,937 |